(Q35743195)

10 August 2017

1 reference

title

Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here? (English)

1 reference

10 August 2017

0 references

Dinesh Khanna

1

1 reference

PubMed ID

15077286

10 August 2017

Maureen McMahon

series ordinal

2

1 reference

PubMed ID

15077286

10 August 2017

Daniel E Furst

series ordinal

3

1 reference

10 August 2017

1 April 2004

1 reference

10 August 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Arthritis & Rheumatology

1 reference

10 August 2017

50

1 reference

10 August 2017

4

1 reference

10 August 2017

1040-1050

1 reference

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha

10 August 2017

1 reference

Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte.

21 January 2018

1 reference

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

21 January 2018

1 reference

Case reports of heart failure after therapy with a tumor necrosis factor antagonist

21 January 2018

1 reference

Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion

21 January 2018

1 reference

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

21 January 2018

1 reference

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.20164

1 reference

10 August 2017

1 reference

PubMed ID

15077286